期刊
INFECTION AND IMMUNITY
卷 74, 期 8, 页码 4910-4914出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/IAI.01860-05
关键词
-
资金
- NIAID NIH HHS [U54 AI057153, 1-U54-AI-057153] Funding Source: Medline
In contrast to Yersinia pestis LcrV, the recombinant V10 (rV10) variant (lacking residues 271 to 300) does not suppress the release of proinflammatory cytokines by immune cells. Immunization with rV10 generates robust antibody responses that protect mice against bubonic plague and pneumonic plague, suggesting that rV10 may serve as an improved plague vaccine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据